Cellyan Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jan '26 Jan 23, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Market Capitalization	9	12	-	-
Enterprise Value	8	14	-	-
Last Close Price	0.83	1.08	-	-
PS Ratio	0.42	0.59	-	-
PB Ratio	1.83	2.38	-	-
P/TBV Ratio	1.86	2.43	-	-
P/FCF Ratio	18.26	23.79	-	-
P/OCF Ratio	16.02	20.87	-	-
EV/Sales Ratio	0.42	0.68	-	-
EV/EBITDA Ratio	31.91	52.12	-	-
EV/EBIT Ratio	44.62	72.87	-	-
EV/FCF Ratio	17.00	27.77	-	-
Debt / Equity Ratio	0.48	0.48	0.49	1.18
Debt / EBITDA Ratio	1.88	1.88	0.80	0.41
Debt / FCF Ratio	4.76	4.76	-	0.43
Asset Turnover	2.25	2.25	2.76	-
Inventory Turnover	23.97	23.97	23.36	-
Quick Ratio	2.65	2.65	1.37	0.88
Current Ratio	2.99	2.99	2.46	1.08
Return on Equity (ROE)	-0.58%	-0.58%	54.96%	-
Return on Assets (ROA)	1.31%	1.31%	17.28%	-
Return on Invested Capital (ROIC)	-3.27%	-2.83%	44.93%	127.37%
Return on Capital Employed (ROCE)	2.90%	2.90%	30.40%	114.30%
Earnings Yield	-0.30%	-0.23%	-	-
FCF Yield	5.48%	4.20%	-	-
Buyback Yield / Dilution	-38.56%	-38.56%	-7.64%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q